Discovering

A disciplined, highly targeted approach to discovering new cancer medicines

Go

Developing

Rigorous, definitive clinical trials based on deep biology and chemistry expertise

Go

Delivering

Committed to bringing differentiated new cancer medicines to patients

Go

Iclusig®(ponatinib)

ARIAD's first internally discovered and developed medicine

Go
       

News & Features

Latest News

1/22/15

ARIAD Announces Appointment of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, as Chief Legal and Administrative Officer

Read More

1/20/15

ARIAD Announces Final Decision from European Commission Endorsing Iclusig’s Approved Indications Throughout Europe

Read More

Our Corporate Brochure

A shared commitment to patients and each other. This is ARIAD.

click here for PDF

Print page Share page
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue